Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul
Novo Nordisk will cut 215 jobs at its Plainsboro, New Jersey headquarters in February 2027, taking 2026 US HQ cuts to 323 as it redesigns its sales force.
Novo Nordisk will cut 215 jobs at its Plainsboro, New Jersey headquarters in February 2027, taking 2026 US HQ cuts to 323 as it redesigns its sales force.
Novartis, Novo, Sanofi, BMS and others say AI has cut early drug discovery time by up to half. The numbers, the frontier AI rivalry and what has not changed.
Novo Nordisk ObesityWeek data show CagriSema users who lost 5% by week 8 reached 25.4% weight loss at 68 weeks, ahead of an FDA decision due in Q4 2026.
China’s 2026 reimbursement list adds 107 drugs, including Pfizer’s ecnoglutide and Innovent’s mazdutide for diabetes, from 1 January 2027.
Novo Nordisk has filed once-daily etavopivat for sickle cell disease with the FDA and EMA after HIBISCUS cut crises by 27%. How it compares with mitapivat.
Novo Nordisk commits US$200M over 2027-2036 to the World Diabetes Foundation for care in low- and middle-income countries. The numbers, track record and strategy.
Novo Holdings has announced a $100 million investment in Swiss biotech firm Asceneuron, aimed at accelerating the development of innovative treatments for neurodegenerative diseases. This strategic funding highlights the potential impact of Asceneuron’s research on the biotech industry and patient care.